Vanguard Global Advisers
MNOV icon

Vanguard Global Advisers’s MediciNova MNOV Stock Holding History

Vanguard Global Advisers’s Portfolio MNOV Stock Details MNOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$20.6K Hold
15,599
– – ﹤0.01% 3324
2026
Q1 		$21.4K Buy
+15,599
New +$23.6K ﹤0.01% 3291

Other funds holding MNOV

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Vanguard Global Advisers's MNOV Position: Q2 2026 in Review

Vanguard Global Advisers held its MediciNova (MNOV) position steady in Q2 2026 at 15,599 shares worth $20.6K. The position accounts for ﹤0.01% of the portfolio, ranked #3324.

Vanguard Global Advisers first reported a position in MNOV in Q1 2026 and has held it in 2 quarters since. The position peaked at $21.4K in Q1 2026. 28 funds tracked by Wall St. Rank hold MNOV as of Q2 2026.

  • Vanguard Global Advisers held 15,599 shares of MediciNova worth $20.6K as of Q2 2026.
  • Vanguard Global Advisers left its MediciNova share count unchanged in Q2 2026.
  • MediciNova made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q2 2026, its #3324 holding.
  • Vanguard Global Advisers first reported a position in MediciNova in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Global Advisers's MediciNova position peaked at $21.4K in Q1 2026.
  • 28 funds tracked by Wall St. Rank held MediciNova as of Q2 2026.

Based on Vanguard Global Advisers's 13F filing for Q2 2026, filed 13 Aug 2026.